OVARIAN SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for recurrent Low-Grade ovarian cancer: targeted drug trametinib shows promise
Disease control CompletedThis study tested whether the targeted drug trametinib works better than standard treatments (like letrozole or chemotherapy) for people with low-grade ovarian or peritoneal cancer that has returned or spread. About 260 adults took part. The goal was to see if trametinib could sl…
Matched conditions: OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:03 UTC
-
Major trial tests best route for ovarian cancer treatment
Disease control CompletedThis study tested whether giving chemotherapy directly into the abdomen (intraperitoneal) works better than into a vein (intravenous) when combined with the drug bevacizumab for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. Over 1,500 participants to…
Matched conditions: OVARIAN SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:52 UTC